Iwata, Y., & Matsumura, T. (2019). Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy. International Journal of Molecular Sciences, 20(16), 3844. https://doi.org/10.3390/ijms20163844
Chicago Style (17th ed.) CitationIwata, Yuko, and Tsuyoshi Matsumura. "Blockade of TRPV2 Is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy." International Journal of Molecular Sciences 20, no. 16 (2019): 3844. https://doi.org/10.3390/ijms20163844.
MLA (9th ed.) CitationIwata, Yuko, and Tsuyoshi Matsumura. "Blockade of TRPV2 Is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy." International Journal of Molecular Sciences, vol. 20, no. 16, 2019, p. 3844, https://doi.org/10.3390/ijms20163844.
Warning: These citations may not always be 100% accurate.